Home › Therapeutic areas › Otorhinolaryngologic agents
Japan market screening · Therapeutic class
耳鼻科用剤 · Japan Standard Commodity Classification
10 molecules in this class are marketed in Japan across 56 products. 4 of those products are not shipping normally today — 7.1% of the class. Supply status is reported to the Ministry of Health, Labour and Welfare and updated daily.
Ordered by how many products compete. Constrained means limited supply or supply suspended; supply suspended does not mean discontinued.
| Molecule | Products | Companies | Constrained | Supply mix |
|---|---|---|---|---|
| Mometasone Furoate Hydrateモメタゾンフランカルボン酸エステル水和物 | 16 | 8 | 2 | |
| Fluticasone Furoateフルチカゾンフランカルボン酸エステル | 14 | 6 | — | |
| Levocabastine Hydrochlorideレボカバスチン塩酸塩 | 11 | 11 | — | |
| Beclometasone Dipropionateベクロメタゾンプロピオン酸エステル | 7 | 6 | 2 | |
| Cefmenoxime Hydrochlorideセフメノキシム塩酸塩 | 2 | 1 | — | |
| Dexamethasone Cipecilateデキサメタゾンシペシル酸エステル | 2 | 1 | — | |
| Dioctyl Sodium Sulfosuccinateジオクチルソジウムスルホサクシネート | 1 | 1 | — | |
| Nicotinamide / Papaverine Hydrochlorideニコチン酸アミド・パパベリン塩酸塩 | 1 | 1 | — | |
| Tetrahydrozoline Hydrochloride / Prednisolone塩酸テトラヒドロゾリン・プレドニゾロン | 1 | 1 | — | |
| Tramazoline Hydrochlorideトラマゾリン塩酸塩 | 1 | 1 | — |
Products counts every marketed product across all strengths and forms, not companies. Companies is the number of companies marketing that molecule; the same company may appear under several molecules, so the column does not add up to a class total. Market size sits on each molecule's own page, valued at national price rather than transaction price. Figures are as at 2026-08-28.
Tell us which molecules matter to you. We will tell you what the public data can and cannot answer before you commission anything.
Send an enquiryOur Database Division replies in English within three business days (Japan time).